Business Context and Reporting Period
This Form 6-K filing by GCL Global Holdings Ltd (GCL) covers the month of July 2025, with the report dated July 8, 2025. The filing discloses a corporate action involving a warrant issuance to a lender in connection with a financing facility.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or overall debt levels. The only specific financial figures disclosed relate to a new financing arrangement:
- Facility Amount: Up to SGD 5,000,000.
- Warrant Shares: 899,281 ordinary shares.
- Exercise Price: US$4.17 per share.
- Aggregate Exercise Price: US$3,750,000.
Material Changes
The material change reported is the issuance of a warrant to Oversea-Chinese Banking Corporation Limited (OCBC) on July 7, 2025. This warrant was issued in connection with a Facility Agreement dated October 1, 2024, and supplemented on March 12, 2025, between OCBC and Epicsoft Asia Pte. Ltd., a wholly-owned subsidiary of GCL.
Outlook, Risks, and Unusual Items
Use of Proceeds: The aggregate exercise price of US$3,750,000 is contractually required to first repay all principal, interest, and other amounts outstanding under the Facility Agreement. Any remainder will be used for the Borrower's working capital.
Registration Obligation: GCL has agreed to file a registration statement for the public resale of the Warrant Shares as soon as reasonably practicable within six months of the warrant date (by January 7, 2026).
Exemption: The warrant was issued in reliance on the Section 4(a)(2) exemption from registration under the Securities Act of 1933.
Investor Verification Checklist
- Verify the current outstanding balance of the Facility Agreement to determine if the full US$3,750,000 exercise price will be available for working capital or if it will be entirely consumed by debt repayment.
- Confirm the status of the registration statement for the public resale of the 899,281 Warrant Shares.
- Review the full text of the Warrant (Exhibit 4.1) for specific terms, conditions, and expiration dates not detailed in this summary.
- Assess the impact of potential dilution from the 899,281 shares if the warrant is exercised.